Package 72789-536-50

{"route": ["ORAL"], "spl_id": "450db2bb-178c-efc2-e063-6294a90a13c0", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0372789536507"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["86c43bdf-c5bf-47cd-8dfd-811263825878"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "50 CAPSULE in 1 BOTTLE, PLASTIC (72789-536-50)", "package_ndc": "72789-536-50", "marketing_start_date": "20251202"}], "brand_name": "acyclovir", "product_id": "72789-536_450db2bb-178c-efc2-e063-6294a90a13c0", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "72789-536", "generic_name": "acyclovir", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA204313", "marketing_category": "ANDA", "marketing_start_date": "20190823", "listing_expiration_date": "20261231"}